HIGHLIGHTS
- who: Posted Date April and collaborators from the China Medical University have published the research work: The role of Interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease, in the Journal: (JOURNAL)
- what: Collectively, the study provided the first human evidence that linking IL-33 to neurodegeneration in the aMCI and AD patients. The study design was observational in nature, and the authors did not observe the findings from the animal study showing that exogenous IL-33 administration rescued AD mice-related brain neuropathology . A previous study found lower baseline levels of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.